Efficacy of systemic Zinc sulphate in prevention of chemotheraphy in duced mucositis in patients with leukemia

Abstract

mucosit is a situation in which the mouth phlegmatic mantle has been inflamed and starts to take injuries. This state is the most prevalent peripheral casualties of malignance treatment E the spread of which vacillates between 40 to 70 percent. Despite using different methods, there has been no absolute and definite treatment for this disease. Using zinc sulfateis one of the many different methods and this study tries to scrutinize its effects on the prevention and cure (arising from chemotherapy) of those infected to leukemia Materials and methods: A group of 140 people who were infected to leukemiawere randomly chosen and divided to two similar bevies. In the prescribed group the zinc was conducted using a protocol of three times chemotherapy per day with a dosage of 220 km/kg. Another multi-vitamin drug (zinc free) was prescribed for the Witness group and it was taken by the sick as an eatable and daily chemotherapy. The data resulting from the findings come from descriptive statistics (mean +standard deviation), frequency percentage and Men Yutniyu Test by dint of Spss. This study statistically considers the amount of 'p' less than 5% to show it as meaningful. Conclusion: Zinc sulfate functions four weeks after the chemotherapy in the direction of detracting and preventing mucosit, while two weeks after the chemotherapy there is no statisticalmeaningful difference between zinc and multi-vitamin